Inventory / revenue moved 2347 bp higher
Inventory / revenue changed +2347 basis points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory / revenue changed +2347 basis points from the comparable as-filed period.
Free-cash-flow margin changed -8313 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed -8335 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current assets changed -10.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Selling, general & administrative changed +38.0% from the comparable as-filed period.
Working capital changed +15.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Stock-based compensation changed +24.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross profit changed +16.8% from the comparable as-filed period.
Capital expenditure changed -24.1% from the comparable as-filed period.
Receivables / revenue changed +3883 basis points from the comparable as-filed period.
Working capital / assets changed +224 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
R&D / revenue changed +166 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Research & development changed +10.9% from the comparable as-filed period.
Total assets changed +4.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Trade receivables changed +10.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Capex / revenue changed -22 basis points from the comparable as-filed period.
SBC / revenue changed +28 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Shares outstanding changed +0.2% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
Operating cash flow / net income changed -102.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory changed +3.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Working capital changed +24.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Inventory changed -23.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Current liabilities changed -26.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Free-cash-flow margin changed -1636 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed -2735 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Working capital / assets changed +395 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Gross profit changed +21.0% from the comparable as-filed period.
Revenue changed -3.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Receivables / revenue changed -1800 basis points from the comparable as-filed period.
R&D / revenue changed +225 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Trade receivables changed -14.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current assets changed -2.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Total assets changed +4.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Shares outstanding changed +0.2% from the comparable as-filed period. The change ranks at the 50th percentile of 8 prior comparable changes.
SBC / revenue changed +5 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash flow / net income changed -178.4% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 2 consecutive comparable moves in the opposite direction.
Stock-based compensation changed +3.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Selling, general & administrative changed -1.2% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.